We are live on ! Find out more
JC

Jacobs & Co Portfolio holdings

AUM $1.17B
1-Year Est. Return 37.3%
This Fund
S&P 500
This Quarter Est. Return
+3.23%
1 Year Est. Return
+37.3%
3 Year Est. Return
+92.23%
5 Year Est. Return
+114.23%
10 Year Est. Return
+410.55%
AUM
$954M
AUM Growth
+$9.5M
Cap. Flow
-$5.76M
Cap. Flow %
-0.6%
Top 10 Hldgs %
31.59%
Holding
125
New
1
Increased
40
Reduced
61
Closed
5

Top Buys

Rank Stock Value
1
NOW icon
ServiceNow
NOW
+$6.35M
2
ROK icon
Rockwell Automation
ROK
+$5.65M
3
MDLZ icon
Mondelez International
MDLZ
+$1.91M
4
ZTS icon
Zoetis
ZTS
+$1.2M
5
MCD icon
McDonald's
MCD
+$1.19M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$4.52M
2
GLW icon
Corning
GLW
+$3.61M
3
NVDA icon
NVIDIA
NVDA
+$2.6M
4
AAPL icon
Apple
AAPL
+$2.31M
5
BUD icon
AB InBev
BUD
+$1.62M

Sector Composition

Rank Sector Weight
1 Technology 30.15%
2 Healthcare 16.16%
3 Industrials 14.45%
4 Consumer Staples 11.39%
5 Consumer Discretionary 10.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GLW icon
76
Corning
GLW
$119B
$2.85M 0.3%
73,413
-103,389
-58% -$3.61M
PYPL icon
77
PayPal
PYPL
$48.9B
$2.85M 0.3%
49,042
-17,001
-26% -$1.08M
WTS icon
78
Watts Water Technologies
WTS
$11.5B
$2.74M 0.29%
14,952
-143
-0.9% -$28.7K
EMR icon
79
Emerson Electric
EMR
$83.9B
$2.43M 0.26%
22,091
-50
-0.2% -$5.53K
ZBH icon
80
Zimmer Biomet
ZBH
$18.2B
$2.2M 0.23%
20,242
-10,136
-33% -$1.19M
TSLA icon
81
Tesla
TSLA
$1.23T
$2.02M 0.21%
10,194
-782
-7% -$137K
MDT icon
82
Medtronic
MDT
$109B
$1.71M 0.18%
21,759
-15,901
-42% -$1.3M
ABNB icon
83
Airbnb
ABNB
$89.9B
$1.68M 0.18%
11,086
-700
-6% -$107K
XOM icon
84
ExxonMobil
XOM
$644B
$1.55M 0.16%
13,439
+300
+2% +$34.9K
VZ icon
85
Verizon
VZ
$195B
$1.41M 0.15%
34,189
-31,634
-48% -$1.27M
RTX icon
86
RTX Corp
RTX
$290B
$1.25M 0.13%
12,456
– –
BUD icon
87
AB InBev
BUD
$170B
$1.17M 0.12%
20,083
-26,462
-57% -$1.62M
ORCL icon
88
Oracle
ORCL
$374B
$1.15M 0.12%
8,136
-1,203
-13% -$149K
BMY icon
89
Bristol-Myers Squibb
BMY
$133B
$1.13M 0.12%
27,289
-101,039
-79% -$4.52M
PNR icon
90
Pentair
PNR
$10.4B
$884K 0.09%
11,534
– –
PLTR icon
91
Palantir
PLTR
$295B
$804K 0.08%
31,768
– –
CL icon
92
Colgate-Palmolive
CL
$73.1B
$770K 0.08%
7,938
– –
GILD icon
93
Gilead Sciences
GILD
$162B
$728K 0.08%
10,622
-16,640
-61% -$1.11M
WFC icon
94
Wells Fargo
WFC
$261B
$608K 0.06%
10,242
-315
-3% -$18.6K
ADSK icon
95
Autodesk
ADSK
$49.5B
$559K 0.06%
2,260
– –
ANET icon
96
Arista Networks
ANET
$227B
$494K 0.05%
5,648
– –
NVT icon
97
nVent Electric
NVT
$24.9B
$478K 0.05%
6,240
– –
ORLY icon
98
O'Reilly Automotive
ORLY
$72.9B
$464K 0.05%
6,600
– –
MSI icon
99
Motorola Solutions
MSI
$72.3B
$445K 0.05%
1,153
– –
JPM icon
100
JPMorgan Chase
JPM
$935B
$429K 0.05%
2,124
-300
-12% -$58.6K
1 2 3
4
5

Similar funds

OCAI
O'Connor Alternative Investments New York $1.17B AUM
BONST
Bank of Nova Scotia Trust Toronto, Ontario, Canada $1.16B AUM 27.04% 1-Year Est. Return
AMI
Amica Mutual Insurance Providence, Rhode Island $1.16B AUM 21.34% 1-Year Est. Return
GAB
German American Bancorp Jasper, Indiana $1.16B AUM 25.7% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return
FG
Fiduciary Group Savannah, Georgia $1.17B AUM 16.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

Jacobs & Co's Q2 2024 Portfolio in Review

As of Q2 2024, Jacobs & Co held 125 positions worth $954M, up 1% from $945M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Trading was light in Q2 2024: portfolio turnover was 4.8%. Jacobs & Co opened 1 new position and exited 5, leaving the 125-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Industrials.

  • Jacobs & Co's largest Q2 2024 buy was Texas Instruments: 1,273 shares worth $247K.
  • Jacobs & Co added most to ServiceNow in Q2 2024, an estimated $6.35M increase.
  • Jacobs & Co's biggest Q2 2024 reduction was Bristol-Myers Squibb, cutting an estimated $4.52M.
  • Jacobs & Co fully exited Stryker in Q2 2024, selling an estimated $679K.
  • Jacobs & Co's ten largest holdings make up 32% of its $954M portfolio in Q2 2024.
  • Jacobs & Co opened 1 new position and closed 5 in Q2 2024.
  • Jacobs & Co's portfolio value rose 1% quarter-over-quarter to $954M.

Based on Jacobs & Co's 13F filing for Q2 2024, filed 12 Jul 2024.